From Phase I to Phase II: Leveraging Early Clinical Data to Inform the Next Stage of Radiopharmaceutical Development
1:30 pm - Thursday 3rd December 2026
- Sharing Phase I clinical findings and evaluating the key efficacy, safety and translational signals emerging from early development
- Understanding how early clinical data can be used to refine patient selection, endpoint strategy and study design ahead of Phase II
- Exploring the operational, clinical and regulatory challenges associated with progressing a radiopharmaceutical programme beyond first-in-human evaluation